Equities

Elite Health Systems Inc

USNU:PKC

Elite Health Systems Inc

Actions
  • Price (USD)1.25
  • Today's Change0.00 / 0.00%
  • Shares traded1.60k
  • 1 Year change+171.74%
  • Beta0.4785
Data delayed at least 15 minutes, as of Nov 19 2024 15:07 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Elite Health Systems Inc had revenues remain flat at 0.00, though the company grew net income from a loss of 1.34m to a smaller loss of 816.00k.
Gross margin--
Net profit margin--
Operating margin--
Return on assets-45.56%
Return on equity-55.92%
Return on investment-49.63%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Elite Health Systems Inc fell by 1.07m. Cash Flow from Financing was even, which indicates that this company's capital needs are balanced. In addition the company used 891.00k for operations while cash used for investing totalled 180.00k.
Cash flow per share--
Price/Cash flow per share--
Book value per share0.2106
Tangible book value per share0.2106
More ▼

Balance sheet in USDView more

Elite Health Systems Inc uses little or no debt in its capital structure.
Current ratio34.31
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 48.45%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-332.03
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.